Literature DB >> 21113596

Interval growth of probably benign breast lesions on follow-up ultrasound: how can these be managed?

Hee Jung Moon1, Eun-Kyung Kim, Jin Young Kwak, Jung Hyun Yoon, Min Jung Kim.   

Abstract

OBJECTIVES: To investigate the malignancy rate in probably benign lesions with interval growth on follow-up ultrasound (US) and the cut-off values for predicting malignancy.
METHODS: By retrospective reviewing 19,435 US examinations assessed as probably benign lesions, a total of 214 lesions with interval growth in 199 patients were included. The increased volume (%V),%V per month, the most increased diameter (D), and D per month were compared between malignant and benign lesions. Malignancy rates were compared between lesions with or without newly developed suspicious malignant features.
RESULTS: Twenty-two (10.3%) malignancies showed significant increase in%V,%V per month, D, and D per month compared with 192 (89.7%) benign lesions (p = 0.0083, <0.0001, <0.0001, and <0.0001, respectively). Fifteen (38.5%) of 39 lesions where suspicious features developed proved malignant, whereas 7 (4%) out of 175 without were malignant (p = 0.0011). In nodules without suspicious features, 24.2% of%V per month and 1.9 mm of D per month showed high sensitivity (85.7% and 71.4%) and specificity (67.8% and 97.6%) for predicting malignancy.
CONCLUSIONS: Probably benign lesions with interval growth should undergo prompt biopsy because of the 10.3% malignancy rate. In lesions where suspicious features developed, the malignancy rate increased to 38.5%.

Entities:  

Mesh:

Year:  2010        PMID: 21113596     DOI: 10.1007/s00330-010-2012-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  BI-RADS for sonography: positive and negative predictive values of sonographic features.

Authors:  Andrea S Hong; Eric L Rosen; Mary S Soo; Jay A Baker
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

2.  Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy?

Authors:  Oswald Graf; Thomas H Helbich; Gottfried Hopf; Claudia Graf; Edward A Sickles
Journal:  Radiology       Date:  2007-07       Impact factor: 11.105

3.  Management of solid breast nodules: what is the role of sonography?

Authors:  V P Jackson
Journal:  Radiology       Date:  1995-07       Impact factor: 11.105

4.  Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases.

Authors:  E A Sickles
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

5.  Enlarging fibroadenoma in a postmenopausal woman: case report.

Authors:  R C Swisher; N R Gade; J J Suk; Y S Fu; L W Bassett
Journal:  Radiology       Date:  1992-08       Impact factor: 11.105

6.  Nonpalpable, probably benign lesions: role of follow-up mammography.

Authors:  X Varas; F Leborgne; J H Leborgne
Journal:  Radiology       Date:  1992-08       Impact factor: 11.105

7.  Malignant lesions initially subjected to short-term mammographic follow-up.

Authors:  Eric L Rosen; Jay A Baker; Mary Scott Soo
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

8.  Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?

Authors:  Oswald Graf; Thomas H Helbich; Michael H Fuchsjaeger; Gottfried Hopf; Margarita Morgun; Claudia Graf; Reinhold Mallek; Edward A Sickles
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

9.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

Authors:  A J Nixon; D Neuberg; D F Hayes; R Gelman; J L Connolly; S Schnitt; A Abner; A Recht; F Vicini; J R Harris
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

Review 10.  Fibroadenoma.

Authors:  D M Dent; P J Cant
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

View more
  8 in total

1.  Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.

Authors:  Su Min Ha; Eun Young Chae; Joo Hee Cha; Hee Jung Shin; Woo Jung Choi; Hak Hee Kim
Journal:  Br J Radiol       Date:  2018-04-25       Impact factor: 3.039

Review 2.  BI-RADS 3 on Screening Breast Ultrasound: What Is It and What Is the Appropriate Management?

Authors:  Wendie A Berg
Journal:  J Breast Imaging       Date:  2021-08-15

3.  Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound.

Authors:  Eun Bi Ryu; Jung Min Chang; Mirinae Seo; Sun Ah Kim; Ji He Lim; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

4.  Breast Imaging Reporting and Data System Category 3 Lesions Detected on Whole-Breast Screening Ultrasound.

Authors:  Sang Yu Nam; Eun Young Ko; Boo-Kyung Han; Jung Hee Shin; Eun Sook Ko; Soo Yeon Hahn
Journal:  J Breast Cancer       Date:  2016-09-23       Impact factor: 3.588

5.  Clinical significance of interval changes in breast lesions initially categorized as probably benign on breast ultrasound.

Authors:  Ja Yoon Jang; Sun Mi Kim; Jin Hwan Kim; Mijung Jang; Bo La Yun; Jong Yoon Lee; Soo Hyun Lee; Bohyoung Kim
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Features of breast cancer initially assessed as probably benign on ultrasound: A retrospective study.

Authors:  Hye Ji Ryu; Joo Hee Cha; Hak Hee Kim; Hee Jung Shin; Eun Young Chae; Woo Jung Choi
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

7.  Benign core biopsy of probably benign breast lesions 2 cm or larger: correlation with excisional biopsy and long-term follow-up.

Authors:  Hyun Kyung Jung; Hee Jung Moon; Min Jung Kim; Eun-Kyung Kim
Journal:  Ultrasonography       Date:  2014-04-10

8.  Follow-Up Intervals for Breast Imaging Reporting and Data System Category 3 Lesions on Screening Ultrasound in Screening and Tertiary Referral Centers.

Authors:  Sun Huh; Hee Jung Suh; Eun Kyung Kim; Min Jung Kim; Jung Hyun Yoon; Vivian Youngjean Park; Hee Jung Moon
Journal:  Korean J Radiol       Date:  2020-09       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.